The Pharmacy Times® Zoster Resource Center is a comprehensive resource for clinical news and expert insights on the reactivation of the chickenpox virus in the body, which causes a painful rash.
August 26th 2025
A novel shingles vaccine candidate demonstrated positive topline results of antibody and CD4⁺ T cell vaccine responses.
Researchers Evaluate Pain Management Therapy Intervention to Treat Chronic Postherpetic Neuralgia
December 23rd 2024Short-term spinal cord stimulation could provide long-term pain relief and improve the overall quality of life for individuals with herpes zoster-associated pain and postherpetic neuralgia.
Read More
Study Finds Upsurge of Shingles Vaccination in Medicare Part D Following Elimination of Cost Sharing
October 3rd 2024The Inflation Reduction Act's zero cost-sharing policy resulted in significant increases in shingles vaccines dispensed to individuals under Part D, compared with those who are commercially insured.
Read More
Latest Developments in mRNA Technology for Vaccines: Moving Beyond COVID-19
March 2nd 2023Due to the success of mRNA technology with COVID-19, there has been a significant increase in research looking into utilizing mRNA technology, and more specifically, how it can help to advance vaccine development.
Read More